FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006152014> ?p ?o ?g. }

• W3006152014 endingPage "1234" @default.
• W3006152014 startingPage "1225" @default.
• W3006152014 abstract "Our previous study demonstrated that Id-1 may promote the tumorigenicity of esophageal squamous cell carcinoma (ESCC). Id-4 is another member of Id family, which is rare to be studied in ESCC. In this study, we investigated the expression of Id-4 in human ESCC specimens and determined whether Id-4 expression was associated with the clinicopathologic characteristic and the prognosis of ESCC patients.We examined Id-4 expression using immunohistochemistry in 92 ESCC tissues and adjacent normal tissues. The association between Id-4 expression and clinical parameters and survival was evaluated by statistical analysis. Cox regression analyses were conducted to identify prognostic factors associated with overall survival (OS). In addition, we explored the functional mechanism of Id-4 in ESCC.Id-4 expression was significantly downregulated in ESCC tissues compared with adjacent normal tissues. The expression of Id-4 was associated negatively with pT stage (p=0.002), AJCC stage (p=0.008) and histologic differentiation (p<0.001). OS was more unfavorable in patients with low expression of Id-4 than those with high expression of ESCC patients (p=0.007). In subgroup analysis, low expression of Id-4 could reveal unfavorable OS of patients with pT1b/T2 stage (p=0.024) or with pN0/N1 stage (p=0.004). By univariate analysis, pT stage and Id-4 expression showed statistically significant associations with OS (p=0.025, p=0.01, respectively). By multivariate analysis, Id-4 expression was an independent prognostic factor in ESCC (p =0.038). In addition, we observed that Id-4 could decrease the levels of the p-Smad2, p-Smad3 and TGF-β1 in both Eca109 and TE1 cells, indicating Id-4 may inactivate the TGF-β signaling pathway.Low expression of Id-4 suggested unfavorable prognosis for ESCC patients and could identify the prognosis in patients of early-stage tumors. The potential mechanism for Id-4's tumor suppressor role in ESCC may be related to its inhibitory effect on TGF-β signaling pathway. Thus, we believe that Id-4 may be a promising prognostic marker and a therapeutic target in ESCC." @default.
• W3006152014 created "2020-02-24" @default.
• W3006152014 creator A5015963155 @default.
• W3006152014 creator A5025041105 @default.
• W3006152014 creator A5027039492 @default.
• W3006152014 creator A5029811844 @default.
• W3006152014 creator A5031734772 @default.
• W3006152014 creator A5066073311 @default.
• W3006152014 creator A5070947544 @default.
• W3006152014 date "2020-02-01" @default.
• W3006152014 modified "2023-10-11" @default.
• W3006152014 title "<p>Expression and Prognostic Value of Id-4 in Patients with Esophageal Squamous Cell Carcinoma</p>" @default.
• W3006152014 cites W1977321706 @default.
• W3006152014 cites W1979210605 @default.
• W3006152014 cites W2003541059 @default.
• W3006152014 cites W2010461434 @default.
• W3006152014 cites W2012988913 @default.
• W3006152014 cites W2049690785 @default.
• W3006152014 cites W2049823677 @default.
• W3006152014 cites W2050871127 @default.
• W3006152014 cites W2064165635 @default.
• W3006152014 cites W2067722046 @default.
• W3006152014 cites W2082833890 @default.
• W3006152014 cites W2097881747 @default.
• W3006152014 cites W2099615047 @default.
• W3006152014 cites W2106454275 @default.
• W3006152014 cites W2135549228 @default.
• W3006152014 cites W2155170820 @default.
• W3006152014 cites W2169385429 @default.
• W3006152014 cites W2272984102 @default.
• W3006152014 cites W2395739137 @default.
• W3006152014 cites W2504051591 @default.
• W3006152014 cites W2580876572 @default.
• W3006152014 cites W2781525129 @default.
• W3006152014 cites W2787553551 @default.
• W3006152014 cites W2856215326 @default.
• W3006152014 cites W2888503569 @default.
• W3006152014 cites W2958392354 @default.
• W3006152014 cites W2963546382 @default.
• W3006152014 cites W3147148312 @default.
• W3006152014 doi "https://doi.org/10.2147/ott.s230678" @default.
• W3006152014 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7024802" @default.
• W3006152014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32103990" @default.
• W3006152014 hasPublicationYear "2020" @default.
• W3006152014 type Work @default.
• W3006152014 sameAs 3006152014 @default.
• W3006152014 citedByCount "2" @default.
• W3006152014 countsByYear W30061520142023 @default.
• W3006152014 crossrefType "journal-article" @default.
• W3006152014 hasAuthorship W3006152014A5015963155 @default.
• W3006152014 hasAuthorship W3006152014A5025041105 @default.
• W3006152014 hasAuthorship W3006152014A5027039492 @default.
• W3006152014 hasAuthorship W3006152014A5029811844 @default.
• W3006152014 hasAuthorship W3006152014A5031734772 @default.
• W3006152014 hasAuthorship W3006152014A5066073311 @default.
• W3006152014 hasAuthorship W3006152014A5070947544 @default.
• W3006152014 hasBestOaLocation W30061520141 @default.
• W3006152014 hasConcept C121608353 @default.
• W3006152014 hasConcept C126322002 @default.
• W3006152014 hasConcept C142724271 @default.
• W3006152014 hasConcept C143998085 @default.
• W3006152014 hasConcept C144301174 @default.
• W3006152014 hasConcept C146357865 @default.
• W3006152014 hasConcept C151730666 @default.
• W3006152014 hasConcept C204232928 @default.
• W3006152014 hasConcept C2779742542 @default.
• W3006152014 hasConcept C2780091936 @default.
• W3006152014 hasConcept C2994415158 @default.
• W3006152014 hasConcept C38180746 @default.
• W3006152014 hasConcept C502942594 @default.
• W3006152014 hasConcept C50382708 @default.
• W3006152014 hasConcept C71924100 @default.
• W3006152014 hasConcept C86803240 @default.
• W3006152014 hasConceptScore W3006152014C121608353 @default.
• W3006152014 hasConceptScore W3006152014C126322002 @default.
• W3006152014 hasConceptScore W3006152014C142724271 @default.
• W3006152014 hasConceptScore W3006152014C143998085 @default.
• W3006152014 hasConceptScore W3006152014C144301174 @default.
• W3006152014 hasConceptScore W3006152014C146357865 @default.
• W3006152014 hasConceptScore W3006152014C151730666 @default.
• W3006152014 hasConceptScore W3006152014C204232928 @default.
• W3006152014 hasConceptScore W3006152014C2779742542 @default.
• W3006152014 hasConceptScore W3006152014C2780091936 @default.
• W3006152014 hasConceptScore W3006152014C2994415158 @default.
• W3006152014 hasConceptScore W3006152014C38180746 @default.
• W3006152014 hasConceptScore W3006152014C502942594 @default.
• W3006152014 hasConceptScore W3006152014C50382708 @default.
• W3006152014 hasConceptScore W3006152014C71924100 @default.
• W3006152014 hasConceptScore W3006152014C86803240 @default.
• W3006152014 hasLocation W30061520141 @default.
• W3006152014 hasLocation W30061520142 @default.
• W3006152014 hasLocation W30061520143 @default.
• W3006152014 hasLocation W30061520144 @default.
• W3006152014 hasOpenAccess W3006152014 @default.
• W3006152014 hasPrimaryLocation W30061520141 @default.
• W3006152014 hasRelatedWork W1889298511 @default.
• W3006152014 hasRelatedWork W2130971557 @default.
• W3006152014 hasRelatedWork W2361700749 @default.

• next